Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII

ASAIO Journal

Volumn 50, Issue 5, 2004, Pages 519-521

  Flynn, Jeremy D ^a   Camp Jr , Phillip C ^b   Jahania, M Salik ^b   Ramaiah, Chand ^b   Akers, Wendell S ^c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CARDIAC SURGERY; CARDIOPULMONARY BYPASS; LEFT VENTRICULAR (LV);

BLOOD; CARDIOLOGY; COAGULATION; PATIENT TREATMENT; PULMONARY DISEASES;

CARDIOVASCULAR SYSTEM;

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CASE REPORT; HUMAN; MALE; SHOCK;

BLOOD COAGULATION DISORDERS; CARDIOPULMONARY BYPASS; FACTOR VII; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 4544312430     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000136516.16726.35     Document Type: Article

References (13)

1. Von Heymann C, Hotz H, Konertz W, Kox WJ, Spies C: Successful treatment of refractory bleeding with recombinant factor Vila after redo coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 16: 615-616, 2002.
2. Naik VN, Mazer CD, Latter DA, Teitel JM, Hare GMT: Successful treatment using recombinant factor Vila for severe bleeding post cardiopulmonary bypass. Canadian Journal of Anesthesia 50: 599-602, 2003.
3. Koh MBC, Hunt BJ: The management of perioperative bleeding. Blood Reviews 17: 179-185, 2003.
4. Goldstein JD, Beauford RB: Left ventricular assist devices and bleeding: Adding insult to injury. Ann Thorac Surg 75: S42-S47, 2003.
5. Dembitsky WP: Bridging from acute to chronic devices. Ann Thorac Surg 68: 724-728, 1999.
6. REMATCH Study Group: Long-term use of left ventricular assist device for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
7. Potapov EV, Pasic M, Bauer M, Hetzer R: Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg 74: 2182-2183, 2002.
8. Hendriks HGD, Van der Maaten JMAA, De Wolf J, Waterbolk TW, Slooff MJH, Van der Meer J: An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 93: 287-289, 2001.
9. Zietkiewicz M, Garlicki M, Domagala J, et al: Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 123: 384-385, 2002.
10. Al Douri M, Shafi T, Al Khudairi D, et al: Effect of the administration of recombinant factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 11: S121-S127, 2000.
11. Hedner U, Erhardtsen E: Potential role for rFVIIa in transfusion medicine. Transfusion 42: 114-124, 2002.
12. Monroe DM, Huffman M, Oliver JA, Roberts HR: Platelet activity of high-dose factor Vila is independent of tissue factor. Br J Haematol 99: 542-547, 1997.
13. Dietrich W, Spannagl M: Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesth Analg 94: 1365-1376, 2002.